U.S. Markets open in 5 hrs 8 mins

Sarepta Therapeutics, Inc. (SRPT)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
43.95+0.54 (+1.24%)
At close: 4:00PM EDT
People also watch
CLVSACADJUNOKITEPTCT
Full screen
Previous Close43.41
Open42.63
Bid43.75 x 100
Ask44.20 x 100
Day's Range42.25 - 44.24
52 Week Range23.28 - 63.73
Volume6,674,510
Avg. Volume2,284,790
Market Cap2.42B
Beta2.20
PE Ratio (TTM)-18.15
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Stocks With MercadoLibre-Like Return Potential
    Motley Fool7 hours ago

    3 Stocks With MercadoLibre-Like Return Potential

    MercadoLibre stock has returned 75% year-to-date. Can you beat that? Let's try.

  • This Biotech Got A Price Hike, But Seesawed After A Three-Day Run
    Investor's Business Daily11 hours ago

    This Biotech Got A Price Hike, But Seesawed After A Three-Day Run

    Sarepta stock toed the line Monday after a three-day run turned negative following its strong second-quarter report last week and a price-target hike.

  • American City Business Journals16 hours ago

    Sarepta may look to bolster pipeline after $250M offering

    Sarepta Therapeutics is planning to raise up to $250 million in a new stock offering, and said it may use some of the proceeds to acquire or license additional drug candidates. The company said that new CEO Douglas Ingram is interested in buying up to $2 million worth of the shares. Proceeds from the offering could be used to license or acquire “complementary products and technologies,” or for a range of other purposes, including to fund clinical trials, commercialization activities and manufacturing, Sarepta said.